| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM)
BLCM Technical Analysis
5
| As on 9th Jun 2023 BLCM STOCK Price closed @ 0.37 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.41 & Strong Sell for SHORT-TERM with Stoploss of 1.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BLCMSTOCK Price
| Open | 0.42 | Change | Price | % |
| High | 0.44 | 1 Day | -0.07 | -15.91 |
| Low | 0.37 | 1 Week | -0.32 | -46.38 |
| Close | 0.37 | 1 Month | -0.05 | -11.90 |
| Volume | 19100 | 1 Year | -1.32 | -78.11 |
| 52 Week High 2.16 | 52 Week Low 0.23 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BLCM Daily Charts |
BLCM Intraday Charts |
Whats New @ Bazaartrend |
BLCM Free Analysis |
|
|
BLCM Important Levels Intraday
| RESISTANCE | 0.50 |
| RESISTANCE | 0.46 |
| RESISTANCE | 0.43 |
| RESISTANCE | 0.41 |
| SUPPORT | 0.33 |
| SUPPORT | 0.31 |
| SUPPORT | 0.28 |
| SUPPORT | 0.24 |
BLCM Forecast May 2024
| 4th UP Forecast | 1.7 |
| 3rd UP Forecast | 1.27 |
| 2nd UP Forecast | 1.01 |
| 1st UP Forecast | 0.75 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.27 |
| 3rd DOWN Forecast | -0.53 |
| 4th DOWN Forecast | -0.96 |
BLCM Weekly Forecast
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.72 |
| 2nd UP Forecast | 0.62 |
| 1st UP Forecast | 0.52 |
| 1st DOWN Forecast | 0.22 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | -0.15 |
BLCM Forecast2024
| 4th UP Forecast | 4.32 |
| 3rd UP Forecast | 3.05 |
| 2nd UP Forecast | 2.27 |
| 1st UP Forecast | 1.49 |
| 1st DOWN Forecast | -0.75 |
| 2nd DOWN Forecast | -1.53 |
| 3rd DOWN Forecast | -2.31 |
| 4th DOWN Forecast | -3.58 |
Bellicum Pharmaceuticals Inc ( NASDAQ USA Symbol : BLCM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BLCM Business Profile
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes when administered after hematopoietic stem cell transplantation in the treatment of hematologic malignancies and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is based in Houston, Texas. Address: 3730 Kirby Drive, Houston, TX, United States, 77098
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service